Craig-Hallum initiated coverage of PolyPid (PYPD) with a Buy rating and $10 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on PYPD: PolyPid announces publication in IJS on Phase 3 SHIELD I trial of D-PLEX100 PolyPid Nears Completion of Key Phase 3 Trial PolyPid enrolls last patient for planned unblinded interim analysis in SHIELD II
